Tivozanib-induced activation of the mitochondrial apoptotic pathway and suppression of epithelial-to-mesenchymal transition in oral squamous cell carcinoma.

Korean J Physiol Pharmacol · 2024 · PMC11058548 · PMID 38682168

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Upon tivozanib treatment, both Ca9-22 and CAL-27 cells displayed an increasing trend in the proportion of cells arrested in the G2 phase, and this was found to be dose-dependent ( Fig. 1D ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.